Epigenomics AGEpigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.05.2022 / 17:39 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of […]
Category: Voting Rights
Please note that we publish incoming notifications of voting rights in the language in which they were received. It may therefore happen that notifications are reproduced on the website exclusively in German or English and not in both languages.
Please send any notification of voting rights with reference to the German Securities Trading Act to the following fax number: +49 30 24345-555
Or to the following e-mail address: voting-rights@epigenomics.com
10. May 2022
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
27. April 2022
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG / Total Voting Rights AnnouncementEpigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 27.04.2022 / 09:58 Total Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Publication […]
27. April 2022
Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AGEpigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung 27.04.2022 / 20:38 Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Stimmrechtsmitteilung 1. Angaben zum Emittenten Name: Epigenomics AG Straße, Hausnr.: Geneststraße 5 PLZ: […]
26. January 2022
Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG26.01.2022 / 10:12 Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Stimmrechtsmitteilung 1. Angaben zum Emittenten Name: Epigenomics AG Straße, Hausnr.: Geneststraße 5 PLZ: 10829 Ort: BerlinDeutschland Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. Grund der Mitteilung Erwerb bzw. […]
24. January 2022
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG / Total Voting Rights Announcement 24.01.2022 / 11:39 Total Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Publication of total number of voting rights1. Details of issuer Epigenomics AG Geneststraße 5 10829 Berlin Germany 2. Type of […]
21. January 2022
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG21.01.2022 / 11:30 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]